First Trust Advisors’s Abiomed Inc ABMD Stock Holding History

First Trust Advisors’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-2,044	Closed	-$502K	–	2606
2022 Q3	$502K	Sell	2,044 -22,477	-92%	-$6.07M	﹤0.01%	2206
2022 Q2	$6.07M	Sell	24,521 -3,141	-11%	-$848K	0.01%	1139
2022 Q1	$9.16M	Buy	27,662 +7,008	+34%	+$2.16M	0.01%	1080
2021 Q4	$7.42M	Buy	20,654 +17,499	+555%	+$5.91M	0.01%	1186
2021 Q3	$1.03M	Sell	3,155 -27,529	-90%	-$9.33M	﹤0.01%	2021
2021 Q2	$9.58M	Sell	30,684 -23,863	-44%	-$7.32M	0.01%	1013
2021 Q1	$17.4M	Sell	54,547 -26,532	-33%	-$8.49M	0.02%	761
2020 Q4	$26.3M	Buy	81,079 +4,131	+5%	+$1.14M	0.03%	554
2020 Q3	$21.3M	Buy	76,948 +66,913	+667%	+$19.3M	0.03%	523
2020 Q2	$2.42M	Buy	10,035 +5,514	+122%	+$1.11M	﹤0.01%	1290
2020 Q1	$656K	Sell	4,521 -2,696	-37%	-$448K	﹤0.01%	1831
2019 Q4	$1.23M	Buy	7,217 +4,441	+160%	+$823K	﹤0.01%	1799
2019 Q3	$494K	Buy	2,776 +747	+37%	+$161K	﹤0.01%	2117
2019 Q2	$529K	Sell	2,029 -40,011	-95%	-$10.6M	﹤0.01%	2092
2019 Q1	$12M	Sell	42,040 -91,909	-69%	-$30.5M	0.02%	682
2018 Q4	$43.5M	Buy	133,949 +29,209	+28%	+$10.1M	0.1%	244
2018 Q3	$47.1M	Sell	104,740 -26,362	-20%	-$10.4M	0.09%	264
2018 Q2	$53.6M	Buy	131,102 +22,901	+21%	+$8.3M	0.11%	197
2018 Q1	$31.5M	Sell	108,201 -13,622	-11%	-$3.45M	0.07%	338
2017 Q4	$22.8M	Buy	121,823 +4,956	+4%	+$925K	0.05%	493
2017 Q3	$19.7M	Buy	116,867 +36,408	+45%	+$5.51M	0.05%	531
2017 Q2	$11.5M	Buy	80,459 +5,777	+8%	+$776K	0.03%	689
2017 Q1	$9.35M	Sell	74,682 -110,458	-60%	-$12.8M	0.03%	786
2016 Q4	$20.9M	Sell	185,140 -71,122	-28%	-$8.24M	0.06%	439
2016 Q3	$33M	Buy	256,262 +237,500	+1,266%	+$28.4M	0.1%	238
2016 Q2	$2.05M	Sell	18,762 -390	-2%	-$38.8K	0.01%	1302
2016 Q1	$1.82M	Sell	19,152 -12,595	-40%	-$1.06M	0.01%	1360
2015 Q4	$2.87M	Buy	31,747 +1,275	+4%	+$108K	0.01%	1203
2015 Q3	$2.83M	Sell	30,472 -18,140	-37%	-$1.6M	0.01%	1204
2015 Q2	$3.19M	Sell	48,612 -29,679	-38%	-$1.97M	0.01%	1254
2015 Q1	$5.6M	Buy	78,291 +17,883	+30%	+$971K	0.02%	1004
2014 Q4	$2.3M	Buy	+60,408	New	+$1.91M	0.01%	1374
2014 Q3	–	Sell	-56,449	Closed	-$1.42M	–	2318
2014 Q2	$1.42M	Sell	56,449 -16,547	-23%	-$385K	0.01%	1536
2014 Q1	$1.9M	Buy	+72,996	New	+$2.02M	0.01%	1416
2013 Q4	–	Sell	-35,167	Closed	-$670K	–	2265
2013 Q3	$670K	Buy	35,167 +24,064	+217%	+$550K	﹤0.01%	1752
2013 Q2	$239K	Buy	+11,103	New	+$223K	﹤0.01%	2101

Other funds holding ABMD

TRSOTSOK

Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

First Trust Advisors's ABMD Position: Q4 2022 in Review

First Trust Advisors sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 2,044 shares — an estimated $502K sold.

First Trust Advisors first reported a position in ABMD in Q2 2013 and held it in 36 quarters. The position peaked at $53.6M in Q2 2018. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

First Trust Advisors reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
First Trust Advisors sold 2,044 Abiomed Inc shares in Q4 2022, an estimated $502K.
First Trust Advisors first reported a position in Abiomed Inc in Q2 2013 and held it in 36 quarters.
First Trust Advisors's Abiomed Inc position peaked at $53.6M in Q2 2018.
8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on First Trust Advisors's 13F filing for Q4 2022, filed 9 Feb 2023.